EUVIMEDEUVIMED entdecken
Crossref

Sodium-glucose cotransporter-2 inhibitor administration recovers peri-implant bone formation in type 2 diabetes: An experimental study using a type 2 diabetes rat model

Tomohiro Masuzaki iD, Fumio Suehiro, Naohiro Komabashiri, Takaharu Shimizu, Masahiro Nishimura

Bio-Medical Materials and Engineering · 2026-11 · 37 (6) · 275-284

DOI: 10.1177/09592989261481043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bio-Medical Materials and Engineering, online erschienen am 21.09.2026. Verfasst von Tomohiro Masuzaki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Geriatric Dentistry, Fukuoka Dental College, Fukuoka, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Experimental, Osteogenesis. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes mellitus is risk factors in implant treatment and maintenance, and it is necessary to consider the effects of diabetes medications.

Objective

This study investigates whether oral administration of sodium-glucose cotransporter 2 (SGLT2) inhibitor, affects bone formation after implant placement.

Methods

A total of 44 Goto-Kakizaki rats were used as a type 2 diabetes model, divided into two groups: the drug administration group (MD) and the non-administration group (GK). A total of 22 Wistar rats were used as the control group (CO). Titanium implants were implanted into the rat tibiae.

Results

Histological and SEM images showed that the GK group had significantly less bone formation than the CO group at both 2 and 4 weeks. No significant differences were observed between groups in serum biochemistry and body weight. Mechanical strength was significantly lower in the GK group than in the CO group at 2 weeks and 4 weeks. Blood glucose levels in the MD group were significantly lower than the baseline values at both 2 weeks and 4 weeks.

Conclusion

In a diabetic rat model, the SGLT2 inhibitor restored implant bone formation without side effects. Further detailed research in clinical settings is needed on the effects of diabetes medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsDiabetes Mellitus, ExperimentalOsteogenesisAnimalsRats, WistarRatsMaleTibiaBlood GlucoseTitanium

Stichwörter der Autor:innen

Mechanical testingdental implantdiabetes mellitusosseointegrationscanning electron microscopy (SEM)

Substanzen

Sodium-Glucose Transporter 2 InhibitorsBlood GlucoseTitanium

Autor:innen und Institutionen

  • Section of Geriatric Dentistry, Fukuoka Dental College, Fukuoka, Japan.
  • Department of Oral and Maxillofacial Prosthodontics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Department of Fixed Prosthodontics and Orofacial Function, Osaka University, Osaka, Japan.

ORCID-Profile: Tomohiro Masuzaki

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Masuzaki, T., Suehiro, F., Komabashiri, N., Shimizu, T., & Nishimura, M. (2026). Sodium-glucose cotransporter-2 inhibitor administration recovers peri-implant bone formation in type 2 diabetes: An experimental study using a type 2 diabetes rat model. Bio-Medical Materials and Engineering, 37(6), 275-284. https://doi.org/10.1177/09592989261481043

Vancouver

Masuzaki T, Suehiro F, Komabashiri N, Shimizu T, Nishimura M. Sodium-glucose cotransporter-2 inhibitor administration recovers peri-implant bone formation in type 2 diabetes: An experimental study using a type 2 diabetes rat model. Bio-Medical Materials and Engineering. 2026;37(6):275-284. doi:10.1177/09592989261481043

BibTeX
@article{Masuzaki2026,
  author = {Masuzaki, Tomohiro and Suehiro, Fumio and Komabashiri, Naohiro and Shimizu, Takaharu and Nishimura, Masahiro},
  title = {Sodium-glucose cotransporter-2 inhibitor administration recovers peri-implant bone formation in type 2 diabetes: An experimental study using a type 2 diabetes rat model},
  journal = {Bio-Medical Materials and Engineering},
  year = {2026},
  volume = {37},
  number = {6},
  pages = {275--284},
  doi = {10.1177/09592989261481043}
}
Kostenlos starten →